{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:53:56Z","timestamp":1767135236676,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":32,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd000162","type":"reference-entry","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:20:09Z","timestamp":1069366809000},"source":"Crossref","is-referenced-by-count":1,"title":["Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke"],"prefix":"10.1002","author":[{"given":"PMW","family":"Bath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FJ","family":"Bath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Asplund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[1996,10,21]]},"reference":[{"issue":"4 suppl 2","key":"10.1002\/14651858.CD000162-BIB1|cit1","first-page":"601","article-title":"Pentoxifylline in the treatment of acute ischaemic stroke - a reappraisal","volume":"21","author":"Chan","year":"1991","journal-title":"Aust N Z J Med"},{"key":"10.1002\/14651858.CD000162-BIB2|cit2","first-page":"110","article-title":"Pentoxifylline in the treatment of acute ischaemic stroke - a reappraisal in Chinese stroke patients","volume":"30","author":"Chan","year":"1993","journal-title":"Clin Exp Neurol"},{"key":"10.1002\/14651858.CD000162-BIB3|cit3","unstructured":"Aschenbrenner KM Addendum to the final report. Efficacy, safety and tolerance of Trental (pentoxifylline) in the treatment of acute non-hemorrhagic focal cerebral infarction (12 - 36 hours after onset) Hoechst AG (HRPI protocol 402 B - modified) 1987"},{"key":"10.1002\/14651858.CD000162-BIB4|cit4","unstructured":"Hentschel B Forthofer R Efficacy, safety and tolerance of Trental (pentoxifylline) in the treatment of acute non-hemorrhagic focal cerebral infarction (12-36 hours after onset). Final report Hoechst (HRPI protocol 402 B - modified) 1986"},{"key":"10.1002\/14651858.CD000162-BIB5|cit5","unstructured":"Clinical\/statistical report for pentoxifylline (Trental, BL 191) Hoechst (Protocol 402A) 1988"},{"issue":"6","key":"10.1002\/14651858.CD000162-BIB6|cit6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/01.STR.19.6.716","article-title":"Pentoxifylline in Acute Nonhemorrhagic Stroke. A randomised, placebo-controlled double-blind trial","volume":"19","author":"Hsu","year":"1988","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000162-BIB7|cit7","first-page":"298","article-title":"Pentoxifylline (PTX) in acute Ischemic stroke","volume":"18","year":"1987","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000162-BIB8|cit8","series-title":"2nd International Conference on Stroke, Geneva","article-title":"Adenosine reuptake inhibition by propentofylline improves brain glucose metabolism as measured by FDG-PET in human acute ischemic stroke. A randomized, placebo-controlled, double-blind study","author":"Huber","year":"1993"},{"key":"10.1002\/14651858.CD000162-BIB9|cit9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/jcbfm.1993.68","article-title":"Effect of Propentofylline on regional cerebral glucose metabolism in acute ischemic stroke","volume":"13","author":"Huber","year":"1993","journal-title":"J Cereb Blood Flow and Metab"},{"key":"10.1002\/14651858.CD000162-BIB10|cit10","series-title":"Abstracts of the 7th Asian Oceanian Congress of Neurology, Bali, September 1987","first-page":"45","article-title":"A control trial of pentoxifylline plus glycerine in the treatment of acute ischemic stroke","author":"Wong"},{"key":"10.1002\/14651858.CD000162-BIB11|cit11","first-page":"20","article-title":"Treatment of acute ischemic stroke","volume":"12","author":"Wong","year":"1987","journal-title":"Bull Neurol Soc (Taiwan)"},{"key":"10.1002\/14651858.CD000162-BIB12|cit12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/030006058901700104","article-title":"Ticlopidine-Pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents","volume":"17","author":"Apollonio","year":"1989","journal-title":"J Int Med Res"},{"issue":"Supp 1","key":"10.1002\/14651858.CD000162-BIB13|cit13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000115660","article-title":"Use of Pentoxifylline in the treatment of acute cerebrovascular insufficiency","volume":"22","author":"Beyreder","year":"1983","journal-title":"Eur Neurol"},{"key":"10.1002\/14651858.CD000162-BIB14|cit14","unstructured":"Kittner B Propentofylline acute stroke study (PASS). HWA 285\/6\/MN\/301\/ST Hoechst Draft Study Protocol 1993"},{"key":"10.1002\/14651858.CD000162-BIB15|cit15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/030006058000800110","article-title":"Pentoxifylline in Strokes: A Clinical Study","volume":"8","author":"Janaki","year":"1980","journal-title":"J Int Med Res"},{"key":"10.1002\/14651858.CD000162-BIB16|cit16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0049-3848(93)90189-U","article-title":"Effects of Dipyridamole, Pentoxifylline or Dipyridamole plus Pentoxifylline on platelet reactivity in patients with ischemic cerebrovascular insufficiency","volume":"72","author":"Santos","year":"1993","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD000162-BIB17|cit17","first-page":"569","article-title":"La Ticlopidina e la pentosifillina nell'infarto cerebrale acuto","volume":"11","author":"Zorzon","journal-title":"G Clin Med"},{"key":"10.1002\/14651858.CD000162-BIB18|cit18","unstructured":"Hoechst Etude multicentrique en double aveugle contre placebo dr l efficacite et de la tolerance du Torental par voie orale dans les infarctus sylviens a la phase aigue Hoechst Internal Report 1985"},{"key":"10.1002\/14651858.CD000162-BIB19|cit19","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1476-5381.1990.tb14097.x","article-title":"Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 rat hippocampus during transient ischaemia","volume":"100","author":"Andine","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1002\/14651858.CD000162-BIB20|cit20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/bmj.311.6998.139","article-title":"Treating acute ischaemic stroke","volume":"311","author":"Bath","year":"1995","journal-title":"Br Med J"},{"key":"10.1002\/14651858.CD000162-BIB21|cit21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00002826-198509000-00009","article-title":"The effect of pentoxifylline on the energy metabolism of ischemic gerbil brain","volume":"8","author":"Bluhm","year":"1985","journal-title":"Clin Neuropharm"},{"key":"10.1002\/14651858.CD000162-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1161\/01.STR.19.12.1535","article-title":"Protection against ischemic brain damage using propentofylline in gerbils","volume":"19","author":"DeLeo","year":"1988","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000162-BIB23|cit23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1212\/WNL.24.5.487","article-title":"Effect of pentoxifylline on cerebral edema in cats","volume":"24","author":"Ganser","year":"1974","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000162-BIB24|cit24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/WNL.27.1.77","article-title":"Effects of pentoxifylline on cerebral ultrastructure of normal and ischemic gerbils","volume":"27","author":"Hartmann","year":"1977","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000162-BIB25|cit25","first-page":"65","article-title":"Haemorheological treatment of acute cerebral ischaemia","volume-title":"Clinical haemorheology - a new approach to cerebrovascular disease","author":"Hartmann","year":"1986"},{"key":"10.1002\/14651858.CD000162-BIB26|cit26","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0140-6736(81)91732-3","article-title":"Randomized trial of pentoxifylline versus acetylsalicylic acid plus dipyridamole in preventing transient ischaemic attacks","volume":"i","author":"Herskovits","year":"1981","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000162-BIB27|cit27","volume-title":"Oxpentifylline","author":"Martindale","year":"1993"},{"key":"10.1002\/14651858.CD000162-BIB28|cit28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00966792","article-title":"An adenosine uptake blocker, propentofylline, reduces glutamate release in gerbil hippocampus following transient forebrain ischaemia","volume":"17","author":"Miyashita","year":"1992","journal-title":"Neurochem Res"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000162-BIB29|cit29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000115658","article-title":"Haemorheological effects of pentoxifylline in disturbed blood flow behaviour in patients with cerebrovascular disease","volume":"22","author":"Ott","year":"1983","journal-title":"Euro Neurol"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000162-BIB30|cit30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000115657","article-title":"The rheological efficiency of parenteral pentoxifylline (Trental) in patients with ischemic brain lesions","volume":"22","author":"Schneider","year":"1983","journal-title":"Europ Neurol"},{"key":"10.1002\/14651858.CD000162-BIB31|cit31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ddr.430070108","article-title":"Effect of propentofylline on the GABA system of a rat brain","volume":"7","author":"Vukadinovic","year":"1986","journal-title":"Drug Dev Res"},{"key":"10.1002\/14651858.CD000162-BIB32|cit32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-198734010-00003","article-title":"Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy","volume":"34","author":"Ward","year":"1987","journal-title":"Drugs"}],"updated-by":[{"DOI":"10.1002\/14651858.cd000162.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2004,7,19]],"date-time":"2004-07-19T00:00:00Z","timestamp":1090195200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD000162\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T16:54:49Z","timestamp":1628528089000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,10,21]]},"references-count":32,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000162","relation":{},"subject":[],"published":{"date-parts":[[1996,10,21]]}}}